James Dao
Amministratore Delegato presso Omnitura Therapeutics, Inc.
Profilo
James Dao is the founder of Genyous Biomed International, Inc., where he holds the title of Chairman & Chief Executive Officer since 2000.
He is also the founder of Omnitura Therapeutics, Inc., where he holds the title of Chairman & Co-Chief Executive Officer since 2001.
Posizioni attive di James Dao
Società | Posizione | Inizio |
---|---|---|
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Amministratore Delegato | 01/01/2001 |
Genyous Biomed International, Inc.
Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Genyous Biomed International, Inc. engages in the discovery, development, and manufacture of multifunctional multi targeted (MFMT) therapies to prevent, detect, and treat cancer and other chronic diseases. The firm offers MFMT therapies, which include anti-viral, anti-oxidative, anti-inflammatory, and immune modulating therapeutic effects for the treatment of solid tumors and related chronic diseases. The company was founded by Jeffrey Dao and James Dao in 2000 and is headquartered in and is headquartered in Henderson, NV. | Amministratore Delegato | 01/01/2000 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
Genyous Biomed International, Inc.
Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Genyous Biomed International, Inc. engages in the discovery, development, and manufacture of multifunctional multi targeted (MFMT) therapies to prevent, detect, and treat cancer and other chronic diseases. The firm offers MFMT therapies, which include anti-viral, anti-oxidative, anti-inflammatory, and immune modulating therapeutic effects for the treatment of solid tumors and related chronic diseases. The company was founded by Jeffrey Dao and James Dao in 2000 and is headquartered in and is headquartered in Henderson, NV. | Technology Services |
- Borsa valori
- Insiders
- James Dao